Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis

Background Quality of life is impaired in patients with sarcoidosis. The King's Sarcoidosis Questionnaire (KSQ) is a brief questionnaire assessing health-related quality of life in patients with sarcoidosis, comprising subdomains of General Health Status (GHS), Lung, Medication, Skin and Eyes....

Full description

Saved in:
Bibliographic Details
Main Authors: Janne Møller, Thomas Skovhus Prior, Ole Hilberg, Surinder Birring, Elisabeth Bendstrup
Format: Article
Language:English
Published: European Respiratory Society 2024-11-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/10/6/00160-2024.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850090529151254528
author Janne Møller
Thomas Skovhus Prior
Ole Hilberg
Surinder Birring
Elisabeth Bendstrup
author_facet Janne Møller
Thomas Skovhus Prior
Ole Hilberg
Surinder Birring
Elisabeth Bendstrup
author_sort Janne Møller
collection DOAJ
description Background Quality of life is impaired in patients with sarcoidosis. The King's Sarcoidosis Questionnaire (KSQ) is a brief questionnaire assessing health-related quality of life in patients with sarcoidosis, comprising subdomains of General Health Status (GHS), Lung, Medication, Skin and Eyes. The aim of this study was to enhance the validation of the KSQ, incorporating longitudinal validation and known-groups validity in a cohort with mild sarcoidosis. Methods The KSQ was linguistically validated according to guidelines. Patients with sarcoidosis completed KSQ and other questionnaires at baseline, after 2 weeks and at 12 months. Forced vital capacity (FVC) was measured. Concurrent validity, reliability and responsiveness were assessed. Results In patients (n=150), the KSQ had moderate to strong correlations with the Short Form-12 (Mental Component Summary), the King's Brief Interstitial Lung Disease questionnaire and the Fatigue Assessment Scale (r=0.30–0.70) and weak correlations with the Short Form-12 (Physical Component Summary) and FVC (r=0.01–0.29). The KSQ GHS and Lung domains were able to discriminate between groups of patients stratified according to fatigue, treatment and FVC. The KSQ had high internal consistency (Cronbach's α=0.73–0.90) and repeatability (interclass correlation coefficients 0.72–0.81). Correlations to comparable questionnaires at baseline were moderate or strong for the GHS, Lung and GHS–Lung subdomains and weak or moderate for FVC. The KSQ was responsive to changes over time. Conclusion This study strengthened the validation of the KSQ by introducing known-groups validity and assessments of responsiveness over 12 months in patients with mild sarcoidosis.
format Article
id doaj-art-eee4e0fd317d4ca889af5feccd4f005d
institution DOAJ
issn 2312-0541
language English
publishDate 2024-11-01
publisher European Respiratory Society
record_format Article
series ERJ Open Research
spelling doaj-art-eee4e0fd317d4ca889af5feccd4f005d2025-08-20T02:42:32ZengEuropean Respiratory SocietyERJ Open Research2312-05412024-11-0110610.1183/23120541.00160-202400160-2024Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosisJanne Møller0Thomas Skovhus Prior1Ole Hilberg2Surinder Birring3Elisabeth Bendstrup4 Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark Department of Medicine, Vejle Hospital, Vejle, Denmark Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark Background Quality of life is impaired in patients with sarcoidosis. The King's Sarcoidosis Questionnaire (KSQ) is a brief questionnaire assessing health-related quality of life in patients with sarcoidosis, comprising subdomains of General Health Status (GHS), Lung, Medication, Skin and Eyes. The aim of this study was to enhance the validation of the KSQ, incorporating longitudinal validation and known-groups validity in a cohort with mild sarcoidosis. Methods The KSQ was linguistically validated according to guidelines. Patients with sarcoidosis completed KSQ and other questionnaires at baseline, after 2 weeks and at 12 months. Forced vital capacity (FVC) was measured. Concurrent validity, reliability and responsiveness were assessed. Results In patients (n=150), the KSQ had moderate to strong correlations with the Short Form-12 (Mental Component Summary), the King's Brief Interstitial Lung Disease questionnaire and the Fatigue Assessment Scale (r=0.30–0.70) and weak correlations with the Short Form-12 (Physical Component Summary) and FVC (r=0.01–0.29). The KSQ GHS and Lung domains were able to discriminate between groups of patients stratified according to fatigue, treatment and FVC. The KSQ had high internal consistency (Cronbach's α=0.73–0.90) and repeatability (interclass correlation coefficients 0.72–0.81). Correlations to comparable questionnaires at baseline were moderate or strong for the GHS, Lung and GHS–Lung subdomains and weak or moderate for FVC. The KSQ was responsive to changes over time. Conclusion This study strengthened the validation of the KSQ by introducing known-groups validity and assessments of responsiveness over 12 months in patients with mild sarcoidosis.http://openres.ersjournals.com/content/10/6/00160-2024.full
spellingShingle Janne Møller
Thomas Skovhus Prior
Ole Hilberg
Surinder Birring
Elisabeth Bendstrup
Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis
ERJ Open Research
title Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis
title_full Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis
title_fullStr Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis
title_full_unstemmed Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis
title_short Longitudinal validation of King's Sarcoidosis Questionnaire in a prospective cohort with mild sarcoidosis
title_sort longitudinal validation of king s sarcoidosis questionnaire in a prospective cohort with mild sarcoidosis
url http://openres.ersjournals.com/content/10/6/00160-2024.full
work_keys_str_mv AT jannemøller longitudinalvalidationofkingssarcoidosisquestionnaireinaprospectivecohortwithmildsarcoidosis
AT thomasskovhusprior longitudinalvalidationofkingssarcoidosisquestionnaireinaprospectivecohortwithmildsarcoidosis
AT olehilberg longitudinalvalidationofkingssarcoidosisquestionnaireinaprospectivecohortwithmildsarcoidosis
AT surinderbirring longitudinalvalidationofkingssarcoidosisquestionnaireinaprospectivecohortwithmildsarcoidosis
AT elisabethbendstrup longitudinalvalidationofkingssarcoidosisquestionnaireinaprospectivecohortwithmildsarcoidosis